Robotic Dog Intervention on Emotional Well-Being and Quality of Life (NCT07607379) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Robotic Dog Intervention on Emotional Well-Being and Quality of Life
28 participantsStarted 2026-07-01
Plain-language summary
The hematopoietic stem cell transplantation (HSCT) process imposes a substantial psychological burden, leading to impaired emotional well-being due to intensive treatment, isolation, and immunosuppression. Patients often experience social withdrawal, loneliness, and loss of control, which may result in persistent anxiety, depressive symptoms, and reduced quality of life (QoL) if unaddressed. This study aims to evaluate the effectiveness, feasibility, and acceptability of an AI-powered robotic dog in improving emotional well-being and QoL in pediatric patients undergoing HSCT.
Who can participate
Age range
8 Years – 15 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pediatric patients aged 8-15 years
* Diagnosed with a hematological malignancy and undergoing hematopoietic stem cell transplantation
* Hospitalized in a protective isolation room during the post-transplant inpatient period
* Expected to remain hospitalized under isolation for approximately 30 days post-transplant
* Able to understand and respond to Turkish-language self-report questionnaires
* Clinically stable and deemed eligible for participation by the treating clinical team
* Able to interact with the robotic dog at a basic functional level
Exclusion Criteria:
* Severe cognitive impairment or neurodevelopmental conditions preventing meaningful interaction or self-report
* Acute neurological conditions, delirium, or severe psychiatric crisis (e.g., acute agitation, suicidal ideation)
* Requirement for intensive care, invasive ventilation, or a clinically unstable condition
* Severe visual, hearing, or motor impairments that prevent interaction with the robotic dog
* Additional infection control restrictions prevent the placement or use of the robotic dog in the isolation room
* Anticipated early discharge, transfer, or inability to complete follow-up assessments
* Severe fear, intolerance, or refusal to interact with robotic or electronic devices
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Positive and Negative Affect
Timeframe: Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
2
Change in Emotional Well-being
Timeframe: Baseline (Day 1, before intervention initiation) and weekly assessments during the intervention period at Weeks 2, 3, and 4.
3
Change in Health-Related Quality of Life
Timeframe: Baseline (Day 1, prior to intervention initiation) and Week 4 (post-intervention assessment after completion of the 4-week intervention period).